OBJECTIVE: The accuracy of the diagnosis is vital when administrative databases are used for pharmacoepidemiologic and outcome studies. Data pertaining to the utility of databases for rheumatoid arthritis (RA) are sparse and variable. We assessed the utility of various diagnostic algorithms to identify RA patients within the Veterans Health Administration (VHA) databases. METHODS: Using the International Classification of Diseases, Ninth Revision code for RA at 2 visits at least 6 months apart, we identified 1,779 patients between October 1, 1998 and September 30, 2009 in our local Veterans Affairs Medical Center (VAMC) administrative database. Disease-modifying antirheumatic drug (DMARD) use was ascertained from the pharmacy database. Cases were analyzed based on DMARD therapy and RA codes at clinic visits. A total of 543 patients' medical records, selected by stratification and random selection on the basis of their visits, were reviewed to ascertain the clinicians' diagnoses and clinical criteria documentation. Positive predictive values (PPVs) were calculated for various database case identification algorithms using diagnosis of RA by medical record review as the gold standard. RESULTS: The PPV for identification of RA with 2 RA codes 6 months apart was 30.9%. Addition of DMARD therapy increased the PPV to 60.4%. The PPV further increased to 91.4% when having an RA code at the last VAMC rheumatology clinic visit criterion was added. An algorithm using only 2 administrative RA codes 6 months apart had a low PPV for correctly identifying patients with RA in the VHA database. CONCLUSION: Including DMARD therapy and requiring an RA code at the last visit with a rheumatologist increased the performance of the data extraction algorithm.
OBJECTIVE: The accuracy of the diagnosis is vital when administrative databases are used for pharmacoepidemiologic and outcome studies. Data pertaining to the utility of databases for rheumatoid arthritis (RA) are sparse and variable. We assessed the utility of various diagnostic algorithms to identify RA patients within the Veterans Health Administration (VHA) databases. METHODS: Using the International Classification of Diseases, Ninth Revision code for RA at 2 visits at least 6 months apart, we identified 1,779 patients between October 1, 1998 and September 30, 2009 in our local Veterans Affairs Medical Center (VAMC) administrative database. Disease-modifying antirheumatic drug (DMARD) use was ascertained from the pharmacy database. Cases were analyzed based on DMARD therapy and RA codes at clinic visits. A total of 543 patients' medical records, selected by stratification and random selection on the basis of their visits, were reviewed to ascertain the clinicians' diagnoses and clinical criteria documentation. Positive predictive values (PPVs) were calculated for various database case identification algorithms using diagnosis of RA by medical record review as the gold standard. RESULTS: The PPV for identification of RA with 2 RA codes 6 months apart was 30.9%. Addition of DMARD therapy increased the PPV to 60.4%. The PPV further increased to 91.4% when having an RA code at the last VAMC rheumatology clinic visit criterion was added. An algorithm using only 2 administrative RA codes 6 months apart had a low PPV for correctly identifying patients with RA in the VHA database. CONCLUSION: Including DMARD therapy and requiring an RA code at the last visit with a rheumatologist increased the performance of the data extraction algorithm.
Authors: J N Katz; J Barrett; M H Liang; A M Bacon; H Kaplan; R I Kieval; S M Lindsey; W N Roberts; D M Sheff; R T Spencer; A L Weaver; J A Baron Journal: Arthritis Rheum Date: 1997-09
Authors: Kimberly J O'Malley; Karon F Cook; Matt D Price; Kimberly Raiford Wildes; John F Hurdle; Carol M Ashton Journal: Health Serv Res Date: 2005-10 Impact factor: 3.402
Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra Journal: Arthritis Rheum Date: 1988-03
Authors: Seo Young Kim; Amber Servi; Jennifer M Polinski; Helen Mogun; Michael E Weinblatt; Jeffrey N Katz; Daniel H Solomon Journal: Arthritis Res Ther Date: 2011-02-23 Impact factor: 5.156
Authors: Zachary J LoVerde; Lisa A Mandl; Beverly K Johnson; Mark P Figgie; Friedrich Boettner; Yuo-Yu Lee; Susan M Goodman Journal: J Rheumatol Date: 2015-05-01 Impact factor: 4.666
Authors: Natalie Jane Shiff; Lisa M Lix; Kiem Oen; Lawrence Joseph; Ciaran Duffy; Elizabeth Stringer; Lori B Tucker; Lawrence W Svenson; Patrick Belisle; Sasha Bernatsky Journal: Rheumatol Int Date: 2014-07-15 Impact factor: 2.631
Authors: Crystal Kleiber Balderrama; Ann K Rosenthal; Daniel Lans; Jasvinder A Singh; Christie M Bartels Journal: Arthritis Care Res (Hoboken) Date: 2017-08-08 Impact factor: 4.794
Authors: Kristin A Sonderman; Lindsey L Wolf; Lindsey B Armstrong; Kathryn Taylor; Wei Jiang; Brent R Weil; Tracey P Koehlmoos; Robert L Ricca; Christopher B Weldon; Adil H Haider; Samuel E Rice-Townsend Journal: Pediatr Surg Int Date: 2018-03-28 Impact factor: 1.827
Authors: Susan M Goodman; Beverly Johnson; Meng Zhang; Wei-Ti Huang; Rebecca Zhu; Mark Figgie; Michael Alexiades; Lisa A Mandl Journal: J Rheumatol Date: 2015-12-01 Impact factor: 4.666
Authors: Ottokar Stundner; Thomas Danninger; Ya-Lin Chiu; Xuming Sun; Susan M Goodman; Linda A Russell; Mark Figgie; Madhu Mazumdar; Stavros G Memtsoudis Journal: J Arthroplasty Date: 2013-06-12 Impact factor: 4.757